Form 8-K - Current report:
SEC Accession No. 0000950170-22-004718
Filing Date
2022-03-28
Accepted
2022-03-28 07:31:11
Documents
14
Period of Report
2022-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20220328.htm   iXBRL 8-K 46886
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 47508
3 GRAPHIC img90053791_0.jpg GRAPHIC 46853
  Complete submission text file 0000950170-22-004718.txt   285169

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20220328_pre.xml EX-101.PRE 11025
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20220328_lab.xml EX-101.LAB 13438
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20220328.xsd EX-101.SCH 2490
8 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20220328_htm.xml XML 4673
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 22773196
SIC: 2834 Pharmaceutical Preparations